These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30426535)

  • 1. Radiolabeling, quality control, biodistribution, and imaging studies of
    Xu Q; Zhang S; Zhao Y; Feng Y; Liu L; Cai L; Zhang W; Huang Z; Wei H; Zhuo L; Chen Y
    J Labelled Comp Radiopharm; 2019 Jan; 62(1):43-51. PubMed ID: 30426535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Absorbed Dose Evaluation of [177Lu]Lu-IBA as a Bone Palliative Candidate.
    Ranjbar H; Pourhabib Z
    Nuklearmedizin; 2021 Oct; 60(5):375-380. PubMed ID: 34102691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases.
    Wang Q; Yang J; Wang Y; Liu H; Feng Y; Qiu L; Chen Y
    Mol Pharm; 2023 Mar; 20(3):1788-1795. PubMed ID: 36802692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, Characterization, and Preliminary Imaging Study of [
    Xu T; Wang Y; Chen Z; Liu H; Yang S; Liu G; Zhao Y; Fu W; Liu L; Xiang K; Peng D; Chen Y
    Contrast Media Mol Imaging; 2022; 2022():7684076. PubMed ID: 35280705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis, radiochemical, and biological characterization of
    Akbar MU; Bokhari TH; Ahmad MR; Zia KM; Roohi S; Ayub N; Sohaib M
    J Cell Biochem; 2019 Sep; 120(9):14510-14517. PubMed ID: 30994957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.
    Benešová M; Umbricht CA; Schibli R; Müller C
    Mol Pharm; 2018 Mar; 15(3):934-946. PubMed ID: 29400475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, quality control, and determination of human absorbed dose of no carrier added
    Salek N; Mehrabi M; Shirvani Arani S; Bahrami Samani A; Erfani M; Vosoghi S; Ghannadi Maragheh M; Shamsaei M
    J Labelled Comp Radiopharm; 2017 Jan; 60(1):20-29. PubMed ID: 27862203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeling, quality control, and biological characterization of 
    Akbar MU; Bokhari TH; Khalid M; Ahmad MR; Roohi S; Hina S; Mehmood S; Sohaib M; Jabbar T
    Chem Biol Drug Des; 2017 Sep; 90(3):425-431. PubMed ID: 28152272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
    Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
    Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Treatment Efficacy of
    Kuo HT; Merkens H; Zhang Z; Uribe CF; Lau J; Zhang C; Colpo N; Lin KS; Bénard F
    Mol Pharm; 2018 Nov; 15(11):5183-5191. PubMed ID: 30251544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy.
    Rasheed R; Tariq S; Naqvi SA; Gillani SJ; Rizvi FA; Sajid M; Rasheed S
    J Labelled Comp Radiopharm; 2016 Aug; 59(10):398-403. PubMed ID: 27444959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
    Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
    Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and dosimetry of
    Li H; Pei W; Yang X; Qu G; Hua Q; Liu L; Wang Y; Xu T; Chen Y
    EJNMMI Res; 2024 Mar; 14(1):30. PubMed ID: 38517637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals.
    Müller C; Farkas R; Borgna F; Schmid RM; Benešová M; Schibli R
    Bioconjug Chem; 2017 Sep; 28(9):2372-2383. PubMed ID: 28898054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics.
    Deberle LM; Benešová M; Becker AE; Ratz M; Guzik P; Schibli R; Müller C
    Bioconjug Chem; 2021 Aug; 32(8):1617-1628. PubMed ID: 34251183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.